BDCOLIST 4.5MIU

Name: BDCOLIST 4.5MIU
Brand: Shivsrushti Surgimed Private Limited
Price: 480.0 INR
Availability: InStock

Price 480.0 INR/ Piece

Get a Price/Quote

MOQ : 50 Pieces

BDCOLIST 4.5MIU Specification

Drug Type
Injection

Ingredients
Product Name: BDCOLIST 4.5 MIU Vial Brand: BDCOLIST 4.5 MIU Vial Content / Active Ingredient: Colistimethate Sodium Injection 4.5 Million IU Company / Manufacturer: BDR Pharmaceuticals Product Description BDCOLIST 4.5 MIU Vial is a sterile injectable antibiotic formulation containing Colistimethate Sodium at a strength of 4.5 Million International Units (MIU) per vial. It belongs to the class of polymyxin antibiotics and is used as a parenteral antibacterial agent for the treatment of serious bacterial infections caused by susceptible Gram negative organisms, especially where other antibiotics are ineffective. Typically supplied as a lyophilized powder for injection, the vial is reconstituted with sterile water for injection and administered intravenously under clinical supervision. Key Features Composition: Colistimethate Sodium 4.5 MIU per vial (sterile powder for injection). Form: Parenteral antibiotic injection (IV administration). Therapeutic Category: Antibiotic Polymyxin class (used for multidrug resistant Gram negative infections). Prescription Status: Schedule H Prescription medicine only. Storage: Store in a cool, dry place away from light. Typical Uses Colistimethate Sodium injections like this are used in the treatment of severe infections caused by Gram negative bacteria (e.g., Pseudomonas aeruginosa, Acinetobacter, Klebsiella), particularly when infections are multi drug resistant and other antibiotics have failed. Important Notes This medicine must be used only under medical supervision with appropriate dosing, monitoring, and clinical judgement. Dosing frequency, infusion rate, and duration should be determined by a healthcare provider based on patient condition and severity of infection. Potential side effects may include renal (kidney) effects, neurotoxicity, and local injection reactions; monitoring of kidney function is often required

Physical Form
Liquid

Recommended For
Doctor

Dosage Guidelines
As per Instructions

Quantity
50 Pieces

Storage Instructions
Cool & Dry Place

Strength
4.5MIU

Molecule
Colistimethate Sodium Injection

BDCOLIST 4.5MIU Trade Information

Minimum Order Quantity
50 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About BDCOLIST 4.5MIU

Product Name: BDCOLIST 4.5MIU Vial

Brand: BDCOLIST 4.5MIU Vial
Content / Active Ingredient: Colistimethate Sodium Injection 4.5Million IU
Company / Manufacturer: BDR Pharmaceuticals

Product Description

BDCOLIST 4.5MIU Vial is a sterile injectable antibiotic formulation containing Colistimethate Sodium at a strength of 4.5Million International Units (MIU) per vial. It belongs to the class of polymyxin antibiotics and is used as a parenteral antibacterial agent for the treatment of serious bacterial infections caused by susceptible Gramnegative organisms, especially where other antibiotics are ineffective.

Typically supplied as a lyophilized powder for injection, the vial is reconstituted with sterile water for injection and administered intravenously under clinical supervision.

Key Features

Composition: Colistimethate Sodium 4.5MIU per vial (sterile powder for injection).

Form: Parenteral antibiotic injection (IV administration).

Therapeutic Category: Antibiotic Polymyxin class (used for multidrugresistant Gramnegative infections).

Prescription Status: Schedule H Prescription medicine only.

Storage: Store in a cool, dry place away from light.

Typical Uses

Colistimethate Sodium injections like this are used in the treatment of severe infections caused by Gramnegative bacteria (e.g., Pseudomonas aeruginosa, Acinetobacter, Klebsiella), particularly when infections are multidrug resistant and other antibiotics have failed.

Important Notes

This medicine must be used only under medical supervision with appropriate dosing, monitoring, and clinical judgement.

Dosing frequency, infusion rate, and duration should be determined by a healthcare provider based on patient condition and severity of infection.

Potential side effects may include renal (kidney) effects, neurotoxicity, and local injection reactions; monitoring of kidney function is often required

Tell us about your requirement